Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Pain in Acute Apical Abscess
NCT06344195Phase 4Recruiting
- Sponsor
- Dow University of Health Sciences
- Start
- Mar 2024
- Primary completion
- Apr 2024
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of valaciclovir in Acute apical abscess (2 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Changes in pain score using Numeric Rating Scale at 6 days. Started Mar 2024; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
Acute apical abscess
Beyond the preview
Go deeper on NCT06344195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06344195.